Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC - 1 Dec 2004

Rouleau Isabelle, Chiquette Jocelyne, Plante Marie, Simard Jacques, Dorval Michel

Abstract excerpt

OBJECTIVE: To determine hormone replacement therapy (HRT)use among women at high risk for breast cancer and ovarian cancer, before genetic testing for the cancer susceptibility genes BRCA1 and BRCA2, and 1 year following disclosure of the test results. METHODS: Participants were 209 French-Canadian women (from 67 high-risk families) who were tested for BRCA1/2 mutations as part of the multidisciplinary research...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Health Behavior

Share to Hormone Replacement Therapy

Share to Mass Screening

Share to Mutation

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 15607041
DOI: 10.1016/s1701-2163(16)30432-7

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy.PMID 15607041Read ↗

Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity Read ↗

Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers.Semantic proximity Read ↗

Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.Semantic proximity Read ↗

Do women change their breast cancer mammogram screening behaviour after BRCA1/2 testing?Semantic proximity Read ↗

Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population.Semantic proximity Read ↗

The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Barriers to hormone therapy following prophylactic bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing.Semantic proximity Read ↗

Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations.Semantic proximity Read ↗

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.Semantic proximity Read ↗

BRCA mutation carriers' perception about benefits and risks associated with combined hormonal contraceptives use.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.